Pharmaceutical Merchants Pharmaceuticals Companies Should "Supply" Customers

The definition of the identity of the pharmaceutical investment enterprise agent is actually very simple and can be divided into two aspects: the old customer and the new customer. Old customers are companies that are collaborating or have previously cooperated, and new customers are companies that, through certain promotional methods, will be attracted to cooperate or have just cooperated. In fact, pharmaceutical investment companies all want to have as many customer resources as possible. They have good ideas for the development of pharmaceutical investment. The fault is that the company does not have a good grasp of the role of old and new customers in the business investment promotion process. The company has certain advantages of loyalty and great sales potential. It is repeating the game of bears and crickets. Each pharmaceutical investment enterprise has its own fixed customers. The cooperation between these customers and enterprises ranges from three months to several years and more than ten years.

In the process of cooperation between these old customers and pharmaceutical investment companies, they have more or less had a certain degree of loyalty to the company, and the risk of cooperation is low. However, the size and strength of the old customers in the pharmaceutical investment enterprise also directly affect the development of the company, which is unstable or continues to rise. For the importance of old customers in the course of business operations, it is evident that the maintenance cost of an old customer to increase sales is only one-fifth of the cost of developing a new customer to obtain the same sales volume. In fact, our pharmaceutical investment enterprise is still quite aware of the importance of the old customers, but it is not effectively integrated in the operation process.

For the company's existing customers to establish a more detailed customer profile, pharmaceutical investment is the key to the effective integration of customer resources, companies must pay attention. The competition of the company's business results is to determine whether the company grasps the market information is profound, whether there is targeted development work. The old customers are also market information and resources. The company can know the operating conditions of the old customers in a timely manner by establishing detailed customer profiles. The market economy system originally did not talk about relationships and feelings. However, influenced by traditional Chinese ideas, companies must find ways to meet customer needs for benefits. From the introduction of products, customers can gain sales benefits, and they can also benefit from assisting customers in implementing effective market development. This is the fundamental way for pharmaceutical investment enterprises to carry out maintenance.

Pharmaceutical Investing Throughout many failures of pharmaceutical investment, often because they do not grasp the psychological needs of dealers and consumers, so that they struggle between the enterprise and the industry. The success of pharmaceutical investment analysis enterprises depends on whether the products can meet the market demand. Most pharmaceutical investment enterprises today do not attach importance to the needs of customers and consumers. They still hold what I can produce and what they can produce. The product either has a single function.

Pharmaceutical investment experts pointed out that the dynamic information management of pharmaceutical investment promotion mainly includes two aspects. The first involves the management of distributor information at the channel level, and the second is the most direct collection and management of consumer data in the market. In the management of distributor information, pharmaceutical investment promotion companies should establish detailed management archives based on the market behavior of distributors, including the major products and the market performance, investment status, staffing, network coverage, and credit information of the distributors. Situations, etc., and based on the development of the market and changes in dealers in a timely manner to eliminate, as a basis for adjusting the channel strategy and related policies. The analysis of pharmaceutical investment agency network is different from the simple classification of dealers. It needs to take the dealer's market behavior as the core, dynamically incorporate the dealer's actual situation and development direction into the management, and it is the market operation of pharmaceutical investment enterprises from Excessive transition to fineness.

Doing a good job in pharmaceutical investment requires gradual and orderly progress. It is not ready to go blindly to attract investment. It is doomed to fail. Prerequisite: Bidding procurement; the success of tender procurement is the prerequisite for successful investment promotion. Pharmaceutical investment promotion companies can only conduct product sales by successfully conducting tender procurement. Therefore, pharmaceutical investment promotion companies must understand the status quo of tendering, analysis and research in countries and regions in daily work. The bidding policy, the focus on tendering, the establishment of internal control systems for corporate bidding, and the awareness of good government public relations and crisis management can only lay the foundation for the success of pharmaceutical investment.